EASD 2019 Interview with Sofia Carlsson European Association for the Study of Diabetes 2026-09-22 | EASD 2019 Interview with Sofia Carlsson
High-resolution approaches to study white adipose tissue in health and cardiometabolic disease European Association for the Study of Diabetes 2025-10-16 | In this EASD Early Career Academy Webinar, Niklas Mejhert and Mikael Rydén from the Karolinska Institutet in Sweden describe how high-resolution spatial approaches applied to human white adipose tissue biopsies from clinical studies can be used to uncover the cellular organisation of the tissue. By integrating spatial transcriptomics and complementary profiling techniques, they aim to better understand adipose tissue biology in both health and cardiometabolic disease.#webinar #diabetes #obesity #diabetesresearch #cellbiology
EASD 2025 - Back to the Future: Re-centring the Role of the Pancreas in Type 2 Diabetes European Association for the Study of Diabetes 2025-10-01 | Discover the work of Dr. Teresa Mezza (Policlinico Universitario Agostino Gemelli), recipient of the 60th Minkowski Prize award at the EASD 2025 in Vienna🏆. In this exclusive interview, she shares how her clinical research on patients after partial pancreatectomy sheds light on the natural history of type 2 diabetes, beta-cell function, and disease progression. Dr. Mezza also highlights her search for new biomarkers to predict diabetes before hyperglycaemia develops, paving the way for precision medicine and better patient care. Her message to young researchers? Believe in your science and keep moving forward. ✨
EASD 2025 - Everything you Want to Know about Adipose Tissue European Association for the Study of Diabetes 2025-10-01 | At the EASD Annual Meeting 2025 in Vienna, Professor Mikael Rydén (Karolinska Institutet, Sweden) was awarded the prestigious 40th Camillo Golgi Prize, honouring his decades of groundbreaking work on adipose tissue, inflammation, and metabolic disease.In this exclusive EASD TV interview, Prof. Rydén reflects on his journey from neurobiology to endocrinology, his pioneering research on fat cell biology and adipose tissue renewal, and how dysfunctional fat drives type 2 diabetes and related conditions. He also shares how his discoveries are shaping the future of precision medicine, linking fat cell subtypes to personalised treatment responses, including bariatric surgery and glucose-lowering drugs.#EASD2025 #T2D #type2diabetes #precisionmedicine #obesity #diabetesresearch
EASD 2025: Precision Diabetes - Learning from the Rare and Applying to the Common European Association for the Study of Diabetes 2025-10-01 | Prof. Andrew Hattersley, University of Exeter, reflects on his remarkable career in diabetes research, following his prestigious Claude Bernard Prize and Lecture at the EASD Annual Meeting 2025. From uncovering the genetic basis of neonatal diabetes to shaping global precision medicine, Hattersley’s journey spans chance discoveries, groundbreaking collaborations, and a worldwide network of clinicians transforming patient care.In this inspiring interview, he shares with our host, Vivienne Parry, how a road trip with a friend who lives with type 1 diabetes sparked his lifelong dedication, how pioneering work in monogenic and neonatal diabetes changed treatment for countless children, and how global collaboration has led to free genetic testing in over 117 countries. Discover how Hattersley’s research continues to influence precision medicine, inspire new generations of scientists, and bring real-world change for patients with diabetes everywhere.#easd2025 #ClaudeBernard #diabetesresearch #genetics #precisionmedicine #globalhealth #diabetescare
EASD 2025: Assessment and Management of Diabetes Distress - The EASDs first clinical guideline European Association for the Study of Diabetes 2025-09-25 | The first-ever EASD Clinical Guideline addresses a vital but often overlooked aspect of diabetes care: diabetes distress. Developed with input from psychologists, clinicians, methodologists, and people living with diabetes, the guideline provides practical recommendations for recognising, assessing, and managing the emotional challenges that come with the condition.In this EASD TV episode, Prof. Jane Speight , Prof. Richard Holt and Michelle Law, who lives with diabetes, discuss how the guideline was created, why it is so urgently needed, and how it can transform everyday clinical practice. Their conversation underlines the importance of moving beyond glucose numbers and placing emotional wellbeing at the centre of person-centred diabetes care.The EASD Diabetes Distress Guideline marks a new step in ensuring that the psychological impact of diabetes is addressed alongside physical health, helping to improve outcomes and quality of life for people with diabetes worldwide.#DiabetesCare #DiabetesDistress #EASDGuideline #EASD2025 #DiabetesManagement #MentalHealthAndDiabetes #EASDtv
EASD 2025 - What if Insulin Resistance Could be Treated like Hypertension or High Cholesterol? European Association for the Study of Diabetes 2025-09-25 | In this episode of EASD TV, host Vivienne Parry sits down with Prof. Gerald "Jerry" Shulman, recipient of the 11th EASD-Novo Nordisk Foundation Diabetes PRize for Excellence prize, to explore his four decades of groundbreaking research into the molecular basis of insulin resistance.From the discovery of diacylglycerols as key drivers of insulin resistance to the development of novel mitochondrial-targeting therapies now in clinical trials, this conversation highlights a potential paradigm shift: treating insulin resistance as a central target in the same way we treat hypertension or high cholesterol.Discover how fat buildup in cells drives type 2 diabetes, fatty liver disease, heart disease, cancers, and Alzheimer’s - and how new therapies targeting the mitochondria could transform treatment.#DiabetesCare #InsulinResistance #MetabolicHealth
EASD 2025 - Impressions and Highlights from Vienna European Association for the Study of Diabetes 2025-09-19 | The #EASD2025 Annual Meeting has come to a close, and we would like to extend our heartfelt thanks to everyone who contributed to making this week such a success.From our delegates and speakers to our exhibitors and organising teams - each of you played a vital role. A special acknowledgement goes to our partners and collaborators, whose support behind the scenes ensured everything ran seamlessly. We truly could not have done it without you!We already look forward to welcoming you next year in Milan for #EASD2026!#ScientificConference #DiabetesResearch #Networking #Vienna #MedicalConference #Diabetes
EASD 2025: Portrait Gerald I. Shulman - Recipient of the 11th EASD-NNF Diabetes Prize for Excellence European Association for the Study of Diabetes 2025-09-17 | From childhood memories at a diabetes camp to groundbreaking discoveries in metabolism, Prof. Gerald Shulman (Yale University) has spent his career unravelling the mysteries of insulin resistance which is a major driver of type 2 diabetes, fatty liver disease, obesity, cardiovascular disease and even Alzheimers.At the EASD 2025 Annual Meeting in Vienna, Prof. Shulman shared how nuclear magnetic resonance (NMR) spectroscopy revolutionised the way scientists see metabolism in real time, revealing how fat fragments jam insulin signalling. His research shows that modest weight-loss, exercise, and innovative therapies can reset the body’s fuel balance, reverse insulin resistance and change the course of disease.Discover why insulin resistance is called the “silent killer” of the 21st century and why tackling it could transform global health.#EASD2025 #DiabetesResearch #InsulinResistance #MetabolicHealth #Type2Diabetes #Obesity #DiabetesCare
EASD 2025: Portrait Teresa Mezza - Recipient of the 60th EASD Minkowski Prize 2025 European Association for the Study of Diabetes 2025-09-16 | Teresa Mezza is Professor of Endocrinology at the Catholic University of the Sacred Heart and a clinician at Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome, Italy. Her research focuses on beta-cell dysfunction and the early phases of type 2 diabetes, aiming to act before complications develop. By combining clinical practice, teaching, and cutting-edge studies, she works to bridge science and patient care in one of Europe’s largest academic hospitals.During the EASD Annual Meeting 2025 in Vienna, Teresa Mezza was awarded the 60th Minkowski Prize, recognising her groundbreaking contributions to understanding the pathophysiology of diabetes, her commitment to prevention, and her leadership in training the next generation of diabetes researchers and clinicians.Her work highlights the global impact of early detection and intervention in diabetes, with insights that influence treatment strategies worldwide.#easd2025 #diabetes #diabetesresearch #type2diabetes #Minkowski #prize
EASD 2025: Portrait Andrew Hattersley - Recipient of the 57th EASD Claude Bernard Prize 2025 European Association for the Study of Diabetes 2025-09-16 | Andrew Hattersley is a Professor of Molecular Medicine at the University of Exeter, UK. His groundbreaking research on the genetic causes of monogenic-diabetes has transformed diagnosis and treatment worldwide. He and his team discovered that mutations in the potassium channel can cause neonatal-diabetes, and crucially, that many patients can switch from insulin injections to oral tablets, changing lives globally. He has also led international collaborations to raise awareness and education around rare forms of diabetes, co-creating the “1 in Six Billion” podcast to connect science and patient voices. During the EASD 2025 Annual Meeting in Vienna, Prof. Andrew Hattersley was awarded the 57th Claude Bernard Prize in recognition of his contributions to advancing genetics in diabetes, his innovative leadership, and his lifetime achievements in diabetes research and care.#EASD2025 #diabetes #diabetesresearch #genetics
Mapping human brown fat: cellular architecture and metabolic implications European Association for the Study of Diabetes 2025-09-03 | In this EASD Early Career Academy webinar, Prof. Kirsty Spalding from the Department of Cell and Molecular Biology at the Karolinska Institute in Stockholm, Sweden, presented unpublished data mapping a cellular atlas of human brown adipose tissue (BAT) from 65 adult donors, using stereology, immunohistochemistry and spatial mapping combined with computational modelling, to show that UCP1⁺ adipocytes are rare, decline with age and BMI, yet are inversely associated with neighbouring white adipocyte size. Strikingly, both spatial analysis and simulations indicate that even modest UCP1⁺ activity can locally reduce white adipocyte size, suggesting these scarce cells exert disproportionate metabolic effects with potential implications for adiposity and systemic energy balance.#metabolism #diabetesresearch #research #cellbiology #molecularbiology
Main pillars of kidney protection in diabetes, and how they may apply in type 1 diabetes European Association for the Study of Diabetes 2025-08-26 | In this EASD Early Career Academy webinar, Prof. Peter Rossing from Steno Diabetes Center in Copenhagen presented the latest developments in kidney protection in diabetes, practical strategies for applying them, and how emerging evidence may shape treatment of chronic kidney disease in type 1 diabetes.Watch the recording to learn more about recent advances in managing chronic kidney disease in type 2 diabetes and the four established pillars of kidney protection. Join Prof. Rossing as he discusses how to use these therapies most effectively. Should treatment be individualized, or should all patients receive all four interventions? Can the successes in type 2 diabetes guide new approaches for type 1 diabetes?#diabetes #diabetescare #type2diabetes #type1diabetes #chronickidneydisease
What’s new in the 2022 ADA/EASD consensus report on the management of hyperglycaemia in T2D? European Association for the Study of Diabetes 2025-06-06 | The 2022 ADA/EASD consensus report reflects a significant shift in the modern approach to diabetes care - one that is holistic, person-centred, and responsive to the lifelong nature of type 2 diabetes. Achieving health equity requires that care strategies also address the social determinants of health. In this webinar, Prof. Tankova explores the latest recommendations on 24-hour physical behaviours - including sleep - and highlights the critical role of diabetes self-management education and support. She covers the risks, benefits, and comparative efficacy of glucose-lowering therapies; options for cardio-renal protection; targeted interventions for weight reduction; and core principles of person-centred care, including the importance of using respectful, inclusive language. The webinar also provides practical tips to support clinicians in implementing these strategies in everyday practice.#diabetes #type2diabetes #hyperglycemia #diabetescare
11th ECA Journal Club - Tracking metabolic phenotypes in preclinical type 1 diabetes European Association for the Study of Diabetes 2025-05-23 | Watch our latest EASD Early Career Academy Journal Club recording featuring Dr. Alfonso Galderisi, Associate Professor of Paediatrics at Yale University, as he discusses his recent research on metabolic phenotypes in preclinical type 1 diabetes.In a study, published in Diabetologia, Dr. Galderisi reveals that in individuals with stage 2 type 1 diabetes, beta cell function and insulin clearance demonstrate distinct trajectories, influenced by both natural progression and responses to immunotherapy like teplizumab. The significant metabolic heterogeneity among individuals at risk of type 1 diabetes, identified as slow- and rapid-progressors, challenge the traditional view on disease progression and response to treatment.This work underscores the potential of using metabolic metrics to refine preclinical stages of type 1 diabetes and improve the design of future prevention trials.Watch the recording now to learn more and read the corresponding paper here: link.springer.com/article/10.1007/s00125-024-06323-0#diabetes #type1diabetes #diabetesresearch #t1d
11th ECA Webinar: SGLT2 inhibitors in type 1 diabetes European Association for the Study of Diabetes 2025-05-09 | Prof. Markus Laimer from the University Hospital Bern in Switzerland reviews current evidence on the metabolic effects of SGLT2 inhibitors in type 1 diabetes, highlights remaining knowledge gaps, and explores future directions for their use in treatment. He evaluates the risk of diabetic ketoacidosis when using SGLT 2 inhibitors in people living with type 1 diabetes and explains why he still considers them a beneficial treatment option in well-controlled and educated patient groups.#diabetes #type1diabetes #diabetestreatment #diabetescare
10th EASD Early Career Academy Journal Club - Postprandial Hypoglycaemia after Gastric Bypass in T2D European Association for the Study of Diabetes 2025-04-01 | Join us for this engaging Journal Club session, where we welcome EASD Early Career Academy Committee Member Domenico Tricò from the University of Pisa!Domenico presents his recently published study in Diabetologia, exploring the mechanisms and clinical impact of postprandial hypoglycaemia after gastric bypass in individuals with a history of type 2 diabetes.He breaks down key findings, revealing how post-bypass hypoglycaemia occurs frequently – often without warning signs – and the underlying pathogenetic mechanisms that could pave the way for future therapeutic strategies.Watch now to learn more about this study at the intersection of diabetes research and metabolic surgery or read it here: link.springer.com/article/10.1007/s00125-024-06312-3#diabetes #hypoglycemia #bariatricsurgery #gastricbypasssurgery #metabolism #research #type2diabetes
EASD 2024: Global Numbers, Big Impact - The future of Type 1 Diabetes Screening and Care European Association for the Study of Diabetes 2025-03-20 | Type 1 diabetes screening is going global! 🌍📊 At the EASD 2024 Annual Meeting, Prof. Annette Ziegler (Helmholtz Munich) and EASD President Prof. Chantal Mathieu discuss groundbreaking efforts to detect type 1 diabetes in its earliest stages. With registries expanding across Europe and public health screening gaining traction worldwide, could early diagnosis change the future of diabetes care? Learn how global data-sharing, innovative screening strategies, and disease-modifying therapies are shaping the next frontier in diabetes prevention. Stay ahead of he latest diabetes research! 🎥#EASD2024 #Diabetes #screening #type1diabetes #globalhealth #earlydetection
EASD 2024: European Diabetes Forum (EUDF) - Shaping Policy for Better Diabetes Care European Association for the Study of Diabetes 2025-03-20 | How can policy drive better diabetes care across Europe? At the EASD 2024 Annual Meeting, we sit down with Bart Torbeyns to explore the crucial role of the European Diabetes Forum (EUDF) in shaping healthcare policies. From uniting key stakeholders to advocating for early invention and improved access to treatment, discover how EUDF is working to bring diabetes and obesity to the forefront of the European health agenda. Learn about the latest initiatives on screening, disease prevention, and the integration of innovative therapies. Stay informed with EASDtv! 🎥#EASD2024 #diabetes #policy #healthcareinnovation #diabetesresearch #obesity #europe
10th ECA Webinar: Predict to plan the future of type 2 diabetes European Association for the Study of Diabetes 2025-02-07 | The growing number of people living with type 2 diabetes poses a major challenge to societies as well as individuals due to an expanding array of costly complications, loss of quality of life and rise of diabetes-related costs. To face this challenge, Prof. Stefano Del Prato presents 4 focus areas: Early detection, Equitable care, Empowerment of people and Embracement of science and technology to discuss what is needed and what may become available to tackle the type 2 diabetes pandemic in the near future.#diabetes #type2diabetes #healthcare #research
EASD 2024: Amylin - A Game-Changer in Diabetes and Obesity Treatment European Association for the Study of Diabetes 2025-01-28 | A once over-looked hormone, Amylin is back in the spotlight at the EASD 2024 Annual Meeting! Join us as experts Thomas Lutz (University of Zurich) and Kirsten Raun (Novo Nordisk) discuss Amylin's exciting potential in treating obesity and type 2 diabetes. From groundbreaking research to innovative Amylin analogues, discover why this hormone might revolutionise metabolic disease treatments. Learn about its unique effects, its synergy with GLP-1, and its promising future.Stay informed about the latest in diabetes research and innovation with EASDtv!#EASD2024 #diabetesresearch #obesitytreatment #amylin #glp1 #metabolichealth #diabetescare
EASD 2024: Putting Diabetes on the Agenda - How to Get Policymakers on Board European Association for the Study of Diabetes 2025-01-28 | Join us for this episode of EASDTV, as Vivienne Parry uncovers how the European Diabetes Forum (EUDF) is uniting countries to improve diabetes care through policy innovation and collaboration. Hear from Bogdan Timor (Romanian Diabetes Forum) and Frank Nobles (Belgian Diabetes Forum) as they share their successes like Romania’s groundbreaking diabetes prevention law and Belgium’s integrated care and data initiatives. Learn why national forums are vital for influencing policymakers and shaping the future of diabetes care in Europe. 🌍💡Stay tuned for more insights from EASD TV, where we bring you the latest in diabetes research, advocacy, and breakthroughs. Subscribe now and explore more at easd.org.#DiabetesCare #EASD2024 #DiabetesPolicy #EUDF #HealthInnovation #DiabetesResearch #EuropeanDiabetesForum #Endocrinology #PublicHealth #DiabetesAdvocacy #EASDTV 🎥💙
EASD 2024: Islet Networks Regulating Insulin Secretion - A Debate European Association for the Study of Diabetes 2025-01-10 | Discover the fascinating world of islet cells beyond beta cells! In this engaging EASDtv episode, Mark Huising and Guy Rutter debate the role of islet networks in glucose regulation. They explore the intricate cross-talk between alpha, beta, and delta cells, shedding light on how these interactions influence insulin secretion and overall islet function. Learn how basic science drives breakthroughs in diabetes research and what this means for future treatments.Subscribe to stay tuned for more insights into diabetes research and innovation!#EASD2024 #diabetesresearch #diabetes #Islet
EASD 2024: How the EASD Early Career Academy is Shaping the Future of Diabetes Research European Association for the Study of Diabetes 2025-01-10 | In this video, we shine a spotlight on the EASD Early Career Academy, a vital initiative supporting early-career researchers and clinicians in diabetes. Join us as we speak with members of the ECA; Beatriz Merino Antolin, Agata Grzelka-Wozniak, Ilke Sen, and Patrick Schrauwen - Chair of the Academy, about their experiences, the Academy's impact, and how it helps shape the future of diabetes research.From mentorship programmes to networking opportunities, discover how the Academy fosters collaboration, skill development, and career growth. Whether you're an early-career academic or simply curious about the next generation of diabetes research leaders, this episode is for you!Watch now to learn more about the ECA and how it's paving the way for innovation in the field of diabetes.#EASD2024 #diabetes #mentorship #earlycareer
Meet the EASD 2024 Rising Stars: Young Researchers Shaping the Future of Diabetes Science European Association for the Study of Diabetes 2025-01-09 | In this inspiring episode, join Vivienne Parry as she introduces the EASD 2024 Rising Stars — a group of dynamic young researchers leading the charge in diabetes and obesity research! 🌟 These brilliant minds are pushing the boundaries of science, from studying the role of adipose tissue and brain functions to exploring innovative, non-pharmaceutical interventions.Meet Borja Martinez-Tellez, Cintia Folgueira-Cobes, Sini Heinonen, and Georgia Colleluori, each with a unique focus in diabetes and obesity research, and hear about their groundbreaking work that earned them the prestigious EASD Rising Star Award.Tune in as they share their unique research interests, their reactions to receiving the award, and what it means for their careers. Plus, get an exclusive look at the support and opportunities these Rising Stars gain to advance their scientific journeys🔬🚀#diabetes #risingstars #diabetesresearch #youngscientists #futureleaders #diabetescare
EASD 2024: What Can We Learn About Diabetes from Indigenous Populations & Genetic Discoveries? European Association for the Study of Diabetes 2025-01-09 | Join Carlos Aguilar Salinas (National Institute of Medical Science and Nutrition, Mexico), Leslie Baier (NIH, Phoenix, Arizona), and Torben Hansen (University of Copenhagen, Denmark) as they discuss their studies on indigenous populations across Greenland, Mexico, and the USA. Discover how unique genetic variations in these communities are reshaping our understanding of diabetes and offering new possibilities for treatment and prevention.#EASD2024 #diabetes #indigenouspeoples #genetics #type2diabetes #globalhealth #medicalscience #diabetesawareness
EASD 2024: The Sky is NOT the Limit! Ensuring Safe Travel for People Living with Diabetes European Association for the Study of Diabetes 2025-01-09 | Ever wondered if flying affects insulin pump performance? ✈️💉At the EASD 2024 Annual Meeting, experts debunked myths and shared groundbreaking insights on how altitude impacts insulin delivery. Featuring David Russell-Jones from the University of Surrey, Julia Mader from the University of Graz, and Bruce King from the University of Newcastle, Australia, this session explores the science behind insulin pumps, bubbles, and altitude changes. Discover practical tips to ensure safe flights for people with diabetes and learn how Europe is paving the way for pilots with diabetes to continue their careers. The discussion highlights the largest hyperbaric chamber study, practical advice for managing insulin during flights, and how modern technology is transforming diabetes care for air travel and safety-critical professions.#EASD2024 #insulinpump #diabetes #diabetescare #diabetesresearch
EASD 2024: Meet the Bright Minds Behind the Best Abstracts of 2024 European Association for the Study of Diabetes 2025-01-09 | Join Vivian Parry on EASD TV as she interviews three extraordinary young researchers whose groundbreaking work earned them the coveted Best Abstract awards at EASD 2024! 🚀✨1️⃣ Henrik Maagensen (Denmark): Specialising in monogenic diabetes, Henrik’s research explores the use of SGLT2 inhibitors for MODY 3 diabetes, offering potential life-changing treatment options.2️⃣ Madeleine Hayman (Belgium): Bridging the gap between mental illness and cardiometabolic diseases, Madeleine investigates the genetic links between GLP1 receptor therapies and mental health.3️⃣ Jolien De Meulemeester (Belgium): Passionate about advancing care for people with type 1 diabetes, Jolien studies the impact of cutting-edge hybrid closed-loop systems on glycaemic control and quality of life.Learn more about their personal journeys, discoveries, and the impact their research could have on diabetes care worldwide. 🌍💡#EASD2024 #abstracts #diabetes #diabetescare #futureleaders
EASD 2024: Diabetologia Journal in Review: Innovations, AI and the Future of Diabetes Research European Association for the Study of Diabetes 2025-01-09 | Join us for an insightful conversation with Prof. Hindrik Mulder, Editor-in-Chief of the Diabetologia Journal, as he reflects on an exciting year for the journal at the EASD 2024 Annual Meeting. From advancements in diabetes research to the impact of AI on publishing, Prof. Mulder shares key highlights, including groundbreaking consensus reports, extended articles, and the future of diabetes therapy. Discover how Diabetologia is shaping the field with its commitment to rigorous science and patient-focused innovation. Don’t miss Prof. Mulder’s preview of the special technology-focused symposium featuring patient voices and the latest issue of Diabetologia!#EASD2024 #diabetologia #diabetesresearch #diabetescare #interview
EASD 2024 - Exercise is Medicine - Physical Activity and Insulin Action in Diabetes European Association for the Study of Diabetes 2024-12-04 | EASDtv Host, Vivienne Parry sits down with Professor Juleen Zierath, recipient of the 2024 EASD–Novo Nordisk Foundation Diabetes Prize for Excellence, to explore her groundbreaking work in exercise physiology and diabetes. From uncovering how exercise counteracts insulin resistance to investigating the molecular mechanisms behind improved glucose metabolism, Professor Zierath sheds light on the profound impact of exercise on diabetes management.Discover how time-of-day exercise, gene expression, and metabolic rhythms shape our understanding of diabetes prevention and treatment. Learn why VO₂ max levels are declining globally and what it means for public health. This is research with real-world implications, inspiring a healthier, more active future.#DiabetesResearch #Exercise #Science #Type2Diabetes #MetabolicHealth #PrecisionMedicine #NovoNordiskFoundation
EASD 2024 - Will Next Generation Obesity Drugs make Bariatric Surgery Obsolete? European Association for the Study of Diabetes 2024-12-04 | Explore the long-going debate on EASDtv as Vivienne Parry hosts Dr Louis Aronne (Weill Cornell Medical College, New York City) and Dr Francesco Rubino (King's College Hospital, London) to discuss whether next-generation medications will make surgery for obesity obsolete. 💊🩺The discussion delves in to the future of obesity treatment, comparing the lates medical therapies to traditional bariatric surgery. With insights on groundbreaking GLP-1 drugs, cost-effectiveness, patient outcomes, and the evolving stigma surrounding obesity, this is a conversation you don't want to miss! Will medications that mimic surgical results revolutionise obesity care, or will surgery continue to play a pivotal role? Watch now and join the conversation! 🔗 Learn more about cutting-edge diabetes research on the EASD Official Website.#obesitytreatment #bariatricsurgery #diabetesresearch #obesity #weightloss #diabetescare
EASD 2024 - Can we Screen for Type 2 Diabetes Using Voice Recognition? European Association for the Study of Diabetes 2024-12-04 | Can your voice reveal type 2 diabetes? In this video by the EASD TV, we talk with Guy Fagherazzi and Abir Elbeji from the Luxembourg Institute of Health about their groundbreaking AI solution that analyses voice to screen for diabetes.Discover how this groundbreaking AI solution, capable of analysing voice signatures with 75% accuracy, could transform diabetes screening globally. With the potential to reach millions through smartphones, this innovation is poised to bridge the gap in undiagnosed cases.Learn more about the cutting-edge research, the challenges faced, and the exciting road ahead for voice-based health diagnostics.#Diabetes #AI #Healthcare #VoiceTechnology #Type2Diabetes #HealthTech #DigitalHealth
EASD 2024 - Producing Beta Cells - Generation of Pancreatic Islets from Stem Cells European Association for the Study of Diabetes 2024-12-04 | In this fascinating EASDtv episode, we dive into the cutting-edge science of stem cell therapy for diabetes with renowned experts Raphael Scharfmann (France) and Valeria Sordi (Italy). Discover the latest advancements in beta cell replacements, the transformative potential of induced pluropotent stem cell (iPSCs), and the future of diabetes treatment. From groundbreaking insights into developmental biology to tackling challenges like immune rejection and scaling u manufacting, this conversation unveils the strides being made toward curing both type 1 and type 2 diabetes. Could an endless supply of lab-grown beta cells revolutionise diabetes care? The answer might be close than you think!#DiabetesResearch #stemcells #type1diabetes #type2diabetes #medicalinnovation #healthtech
EASD 2024 - Help! I Need Somebody - Complex Diabetes Cases in the Emergency Room European Association for the Study of Diabetes 2024-12-04 | In this session from EASDtv, experts dive into the critical topic of glucose emergencies in the emergency department. Dr. Epha Egan from the Mayo Clinic (US) and Dr. Daniel Morenstein from the Royal Marsden Hospital (UK) discuss the challenges of managing glycemic emergencies in high-risk patient groups, including pregnant women with diabetes and cancer patients undergoing treatment. They highlight the importance of early recognition, timely intervention, and the need for a multi-disciplinary approach to ensure better patient, hypoglycemic emergencies linked cancer drugs, and the complexities of managing diabetes in patient with cancer,Tune in for essential insights from leading experts in the field! 💉⚠️👩⚕️#diabetescare #glucose #diabetic #pregnancycare #cancercare #emergency
EASD 2024 - When Sex is Ex - Sexual Problems in Diabetes European Association for the Study of Diabetes 2024-12-04 | In this eye-opening session, we delve into the often-overlooked connection between diabetes and sexual health. Sexual difficulties are highly prevalent among individuals with diabetes, yet they remain a taboo subject in many doctor-patient conversations. Join Sexologist, Marieke Dewitte and Diabetologist, Aleksandra Uruska as they explore the common issues and discuss the broader biopsychosocial factors at play. Don't miss this important discussion that challenges the stigma and encourages more open, honest dialogue. Hit the subscribe button for more insightful content from the EASD! 🌟#diabetes #diabetescare #diabetesresearch #sexualhealtheducation
EASD 2024 - Saving Hearts, Kidneys and Lives in Type 2 Diabetes - Results from the FLOW Trial European Association for the Study of Diabetes 2024-12-04 | In this exciting episode, experts from across the world delve into the groundbreaking results of the FLOW study, which has significantly impacted the treatment of Chronic Kidney Disease (CKD) and cardiovascular health. The FLOW study, the first dedicated trial to investigating a GLP-1 receptor agonist for CKD, shows incredible benefits , including a 24% reduction in kidney complications, improved heart health, and a 20% reduction in total mortality rates. Join Richard Pratley, Peter Rossing, Katherine Tuttle as they break down the latest findings and discuss how these results will shape future treatment strategies for diabetes and CKD patients. This is a game-changer for those with advanced kidney disease, with benefits extending to cardiovascular health and weight management. To learn more on how to save kidneys, hearts and lives with the power of science, watch the video and subscribe for more EASD content. #FLOW #diabetescare #kidneydisease #heartfailure #chronickidneydisease
EASD 2024 - Can Pre-diabetes Remission Reduce Global Diabetes Incidence? European Association for the Study of Diabetes 2024-12-04 | Join Vivian Parry on EASDtv as she discusses the groundbreaking topic of pre-diabetes and remission with Dr Andreas Birkenfeld (Germany) and Dr Viswanathan Mohan (India). Learn about the innovative strategies aimed at tackling pre-diabetes, its potential for remission, and its massive global implication. Discover why early screening for pre-diabetes is crucial, the challenges faced by healthcare systems worldwide, and how countries can adapt policies to prevent diabetes escalation. Hear compelling stories, expert insights, and actionable strategies for improving public health. Find out how awareness, health economics, and policy changes can make pre-diabetes remission a global reality. With predictions of 1.5 billion diabetes cases by 2050, this conversation is more important than ever. Don’t miss this vital discussion—watch now and stay informed!#prediabetes #diabetescare #diabetesprevention #globalhealth #remission
EASD 2024 - Old and New Islets for Type 1 Diabetes European Association for the Study of Diabetes 2024-12-04 | Discover the evolution of cell therapy in diabetes management, from pancreas and islet transplants to cutting-edge stem cell advancements. Join experts Dr James Shaw (Newcastle University), Dr Timothy Kieffer (University of British Columbia & Fractal Health), and Dr Trevor Reichman (University of Toronto) as they explore how these therapies are transforming lives. Learn about the promise of stem cell-derived islets, groundbreaking clinical trials, and innovative approaches like gene editing and encapsulation for immune evasion. This discussion offers a glimpse into the future of diabetes care, with therapies designed to be safer, more accessible, and potentially life-changing.👉 Stay informed, stay inspired—watch now!#DiabetesResearch #CellTherapy #StemCells #DiabetesCare #Type1Diabetes #DiabetesCure #EASDtv #MedicalBreakthroughs #ScienceInnovation #FutureOfMedicine #GeneTherapy 🧬💡🌍
EASD 2024 - The Future of Type 2 Diabetes - Where Are We Going? European Association for the Study of Diabetes 2024-12-04 | Dive into the future of type 2 diabetes treatment with this thought-provoking discussion featuring experts Emma Alqvist from Lund University and Matthias Blüher from Leipzig University. Discover groundbreaking insights into personalised medicine, advancements in treatment options, and the integration of AI and machine learning to redefine how we understand and manage this complex condition. This session explores key topics such as the potential GLP-1 therapies, the stigma around obesity and diabetes, innovative screening technologies, and the global disparities in access to care. Gain a deeper understanding of the role of phenotyping and stratification in tailoring treatments and learn how early diagnosis and intervention can revolutionise patient outcomes. Stay ahead of the curve in diabetes research and healthcare. Watch now to explore how science and technology are shaping a healthier tomorrow 🌍💊#Type2Diabetes #diabetestreatment #precisionmedicine #obesity #diabetes #innovation
EASD 2024 - The Future of Technology in Diabetes Care European Association for the Study of Diabetes 2024-12-04 | Step into the world of diabetes technology as we reflect on its transformative journey, from the challenges of early treatment methods to the advanced, life-enhancing innovations of today. This engaging discussion dives into cutting-edge developments in diabetes care, featuring experts Anna Krook (Karolinska Institute), Klemen Dovč (Slovenia), Pieter Gillard (University Hospital Leuven), and Julia Mader (University of Graz).Learn how technology is improving care for all ages, reducing burdens, and addressing equity in access. Plus, discover future trends like multi-metabolite sensors and fully automated systems.The panel also explores exciting future trends, including multi-metabolite sensors, AI-driven solutions, and fully automated "no-touch" systems that promise to make life easier for people living with diabetes.🔗For more insights, check out the special Diabetologia supplement, available the EASD official website. #Diabetes #DiabetesTechnology #GlucoseMonitoring #AutomatedInsulin #EquityInHealthcare
EASD 2024 - Identifying the Genetic Causes of Neonatal Diabetes European Association for the Study of Diabetes 2024-12-04 | Join us as Dr. Elisa De Franco, recipient of the EASD's prestigious Minkowski Lecture Award, shares her groundbreaking research into #neonatal #diabetes— a rare form of diabetes in babies under six months old. 🧬 Elisa discusses her role in identifying key genetic mutations that transform patient care and deepen our understanding of beta cell biology.Learn how Exeter has become a global hub for neonatal diabetes diagnostics and how Elisa's work is uncovering new insights into diabetes mechanisms, including Type 1 and Type 2 diabetes. 🌍#diabetesresearch #neonataldiabetes #genetics #betacellbiology
EASD 2024 - The Future of Type 1 Diabetes - Will We See Prevention or Cure? European Association for the Study of Diabetes 2024-11-26 | In this episode, join Vivienne Parry as she sits down with renowned experts— EASD President Prof. Chantal Mathieu, Dr. Peter Rossing, and Dr. Rory McCrimmon—to discuss promising developments in early detection, intervention, and even potential vaccines to halt the progression of Type 1 diabetes.This episode delves into:🔬 Early screening and prevention breakthroughs💉 Disease-modifying therapies🌱 The potential for a type 1 diabetes vaccine to protect against the autoimmune triggers of Type 1 diabetes📈 Innovative technologies like hybrid closed-loop systems, transforming diabetes care🩺 The evolving role of type 2 diabetes drugs in type 1 management and outcomesWith breakthroughs in research and technology, we are closer than ever to a future where Type 1 diabetes could be prevented or managed more effectively. Tune in to learn how these innovations will change the landscape of diabetes care for future generations! 🚀#type1diabetes #diabetesresearch #diabetescare #healthtech
EASD 2024 - Metabolic Mastermind: Adipose Tissues Role in Energy and Glucose Control European Association for the Study of Diabetes 2024-11-26 | Adipose tissue isn't just "fat"—it's a remarkable endocrine organ with transformative impacts on health and diabetes. In this EASDtv episode, discover groundbreaking insights from Dr Alice Williamson of Queen Mary University, London, and Dr Laurie Goodyear of Harvard Medical School.🧬 Learn about the genetic factors behind insulin resistance and the revolutionary role of exercise in remodelling adipose tissue. From genetic breakthroughs to potential therapies, this discussion unpacks the exciting future of #diabetes care.👉 Find out why fat is more than just a roll around your middle—it’s a key player in metabolic health!💡 Don’t miss this eye-opening exploration of diabetes science and innovation.📢 Subscribe to stay updated with the latest in diabetes research!#exercise #insulinresistance #type2diabetes #metabolichealth #endocrine
EASD 2024 - How the UK Revolutionised Diabetes Care with CGM & Artificial Pancreas European Association for the Study of Diabetes 2024-11-25 | Discover how the UK became a global leader in diabetes care with universal CGM access and artificial pancreas systems. In this exclusive EASDtv interview, Dr Partha Kar shares key insights on patient advocacy, clinician collaboration, and transforming healthcare policy.Learn how these advancements are changing lives and what other countries can do to follow suit. 💡🎥 Subscribe for more insights into diabetes innovation!#DiabetesCare #CGM #ArtificialPancreas #diabetes #technology #healthinnovation #type1diabetes #patientadvocacy #chronicdiseases
EASD 2024 - Breaking Barriers: Public-Private Partnerships Revolutionising Diabetes Research European Association for the Study of Diabetes 2024-11-25 | What happens when academia and pharma join forces? Discover how groundbreaking collaborations between researchers and industry leaders like Lilly and Sanofi are reshaping diabetes care. 🌍 From pre-competitive initiatives to patient-driven innovations, this discussion dives into the transformative power of partnerships. Featuring Dr Melissa Thomas, Dr Elisabeth Niemoller, and Dr Michele Solimena, hosted by Vivienne Parry.👉 Explore how these alliances are accelerating therapies, enhancing research, and prioritising patient impact. Don’t miss insights into the future of diabetes care!🔗 Watch now and join the conversation.#diabetes #medicalscience #partnership #innovativemedicine #diabetescare
EASD 2024: EAST-WEST Forum - The Future of Patient and Public Involvement in Diabetes Research European Association for the Study of Diabetes 2024-11-25 | In this insightful episode of EASDtv, experts from East and West come together to discuss the crucial topic of patient and public involvement (PPI) in diabetes research. Featuring distinguished speakers: Dai Yabe from Kyoto University, Haruka Nakada from Tokyo University, Sean Dinneen from the University of Galway, and Ingrid Willaing from the Danish Endocrine and Diabetes Academy, the forum explores how patient voices can shape research priorities and clinical trials, highlighting challenges and opportunities in both regions.📌Watch this engaging discussion and discover how patients and the public can play an active role in advancing diabetes research globally.🔔 Don't forget to subscribe for more updates!#diabetesresearch #medicalinnovation #globalcollaboration #publicengagement #diabetescare #diabetesawareness #researchinnovation
EASD 2024 - Understanding New Guidelines - Metabolic Dysfunction-Associated Steatotic Liver Diseases European Association for the Study of Diabetes 2024-11-25 | Discover the latest updates in the field of Metabolic Dysfunction-Associated Steatotic Liver Diseases (MASLD), formerly known as Non-Alcoholic Fatty Liver Disease (NALFD). In this insightful session from the EASD 2024 Annual Meeting, experts Dr. Frank Tacke, Dr. Hannele Yki-Järvinen, and Prof. Michael Roden discuss the reasons behind the new terminology, the integration of Liver Specialists and Diabetologists, and the evolving treatment guidelines. Learn about innovative diagnostic tools, promising treatments, and the vital role of #weight #management and lifestyle interventions.📚 Stay informed on advancements that bridge #diabetes and #liver #health!🔗 Explore EASD resources for more expert discussions - Link in Bio!
EASD 2024 - Finding the Balance: Work-Life Strategies for Early Career Academics European Association for the Study of Diabetes 2024-11-25 | Discover valuable insights on achieving work-life balance as an early career academic from our dynamic discussion on EASD TV. Hear from Anna Krook (Karolinska Institute, Sweden) and Benoit Gauthier (Andalusian Molecular Biology and Regenerative Medicine Centre - CABIMER , Spain) as they share personal strategies, challenges, and solutions for juggling research, teaching, and family life. Learn about the importance of mentorship, prioritisation, and finding a supportive environment.Watch now and take the first step towards balancing your professional and personal life with purpose and passion!#worklifebalance #academia #research #support
EASD 2024 - What Will the Future Bring for People Living with Diabetes? European Association for the Study of Diabetes 2024-11-25 | In this video, EASD Host Vivienne Parry explores the future of diabetes care. Joined by Bastian Hauck (Dedoc), Renza Scibilia, and Christian Collin (Denmark), they discuss advancements in Type 1 prevention, equitable access to therapies, and the role of advocacy. From cutting-edge genetic testing to innovative screening tools, the panel reflects on global challenges, systemic barriers, and the power of community in transforming diabetes care.🌍 Don't miss this engaging conversation as we discuss how the diabetes community, from researchers to advocates, is shaping a brighter, healthier future for people living with diabetes.#DiabetesCare ##DiabetesAwarenes #Type1Diabetes #Type2Diabetes #Prevention #DiabetesResearch #HealthEquity #DiabetesCommunity
EASD2024 - Advancements in Diabetes Care: Technology in Hospitals, Pregnancy, & Gestational Diabetes European Association for the Study of Diabetes 2024-11-25 | In this insightful discussion on EASD TV, Vivian Parry talks with experts Hood Tabit and Helen Murphy about the role of technology in managing diabetes, particularly in hospitals and during pregnancy. Hood explores the challenges hospitals face in implementing diabetes management guidelines and how technology could help bridge the gap. Helen discusses advancements in diabetes care for pregnant women, including the success of continuous glucose monitoring (CGM) and its impact on improving maternal and neonatal health. They also touch on the rising prevalence of gestational diabetes and the need for better healthcare systems to support women long-term.#DiabetesCare #TechnologyInHealthcare #CGM #DiabetesManagement #PregnancyCare #GestationalDiabetes #HealthTech #EASD #Diabetologia #WomenHealth #HospitalCare #NHS #DiabetesAwareness
